AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo

被引：19
作者：
Yu, M. [1 ,2 ]
Gang, E. J. [3 ,4 ]
Parameswaran, R. [1 ,2 ]
Stoddart, S. [1 ,2 ]
Fei, F. [1 ,2 ]
Schmidhuber, S. [1 ,2 ]
Park, E. [3 ,4 ]
Hsieh, Y. T. [3 ,4 ]
Yang, A. S. [5 ]
Groffen, J. [1 ,2 ,3 ,4 ]
Heisterkamp, N. [1 ,2 ,3 ,4 ]
Kim, Y. M. [3 ,4 ]
机构：
[1] Childrens Hosp Los Angeles, Sect Mol Carcinogenesis, Div Hematol Oncol, Los Angeles, CA 90027 USA
[2] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA
[3] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA
[4] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
[5] Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Ctr Blood Dis,Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA
来源：
BLOOD CANCER JOURNAL | 2011年 / 1卷
关键词：
CXCR4; ANTAGONIST; MICROENVIRONMENT; MOBILIZATION; RESISTANCE; INHIBITORS; AML;
D O I：
10.1038/bcj.2011.13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e14 / e14
页数：3
相关论文
共 8 条
  • [1] CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
    Azab, Abdel Kareem
    Runnels, Judith M.
    Pitsillides, Costas
    Moreau, Anne-Sophie
    Azab, Feda
    Leleu, Xavier
    Jia, Xiaoying
    Wright, Renee
    Ospina, Beatriz
    Carlson, Alicia L.
    Alt, Clemens
    Burwick, Nicholas
    Roccaro, Aldo M.
    Ngo, Hai T.
    Farag, Mena
    Melhem, Molly R.
    Sacco, Antonio
    Munshi, Nikhil C.
    Hideshima, Teru
    Rollins, Barrett J.
    Anderson, Kenneth C.
    Kung, Andrew L.
    Lin, Charles P.
    Ghobrial, Irene M.
    [J]. BLOOD, 2009, 113 (18) : 4341 - 4351
  • [2] Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
    Broxmeyer, HE
    Orschell, CM
    Clapp, DW
    Hangoc, G
    Cooper, S
    Plett, PA
    Liles, WC
    Li, XX
    Graham-Evans, B
    Campbell, TB
    Calandra, G
    Bridger, G
    Dale, DC
    Srour, EF
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08) : 1307 - 1318
  • [3] Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro
    Juarez, J
    Bradstock, KF
    Gottlieb, DJ
    Bendall, LJ
    [J]. LEUKEMIA, 2003, 17 (07) : 1294 - 1300
  • [4] CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment
    Juarez, J.
    Dela Pena, A.
    Baraz, R.
    Hewson, J.
    Khoo, M.
    Cisterne, A.
    Fricker, S.
    Fujii, N.
    Bradstock, K. F.
    Bendall, L. J.
    [J]. LEUKEMIA, 2007, 21 (06) : 1249 - 1257
  • [5] Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia
    Kaur, Pavinder
    Feldhahn, Niklas
    Zhang, Bin
    Trageser, Daniel
    Muschen, Markus
    Pertz, Veerle
    Groffen, John
    Heisterkamp, Nora
    [J]. MOLECULAR CANCER, 2007, 6 (1)
  • [6] Resistance to imatinib of Bcr/Abl p190 lymphoblastic leukemia cells
    Mishra, Suparna
    Zhang, Bin
    Cunnick, Jess M.
    Heisterkamp, Nora
    Groffen, John
    [J]. CANCER RESEARCH, 2006, 66 (10) : 5387 - 5393
  • [7] Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
    Nervi, Bruno
    Ramirez, Pablo
    Rettig, Michael P.
    Uy, Geoffrey L.
    Holt, Matthew S.
    Ritchey, Julie K.
    Prior, Julie L.
    Piwnica-Worms, David
    Bridger, Gary
    Ley, Timothy J.
    DiPersio, John F.
    [J]. BLOOD, 2009, 113 (24) : 6206 - 6214
  • [8] Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
    Zeng, Zhihong
    Shi, Yue Xi
    Samudio, Ismael J.
    Wang, Rui-Yu
    Ling, Xiaoyang
    Frolova, Olga
    Levis, Mark
    Rubin, Joshua B.
    Negrin, Robert R.
    Estey, Elihu H.
    Konoplev, Sergej
    Andreeff, Michael
    Konopleva, Marina
    [J]. BLOOD, 2009, 113 (24) : 6215 - 6224
1